Acacia Research Corporation
General ticker "ACTG" information:
- Sector: Industrials
- Industry: Specialty Business Services
- Capitalization: $362.1M (TTM average)
Acacia Research Corporation follows the US Stock Market performance with the rate: 28.8%.
Estimated limits based on current volatility of 1.9%: low 4.89$, high 5.06$
Factors to consider:
- Total employees count: 1042 (+505.8%) as of 2024
- US accounted for 68.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Acquisition/divestiture risks, Integration challenges, Labor/talent shortage/retention, Supply chain disruptions
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.12$, 4.96$]
- 2026-12-31 to 2027-12-31 estimated range: [3.39$, 5.32$]
Financial Metrics affecting the ACTG estimates:
- Positive: with PPE of 12.4 at the end of fiscal year the price was very low
- Positive: Operating cash flow per share per price, % of 20.97 > 12.96
- Positive: -4.72 < Operating profit margin, % of 2.25
- Negative: Investing cash flow per share per price, % of -5.85 <= -4.45
- Negative: 0.73 < Interest expense per share per price, % of 2.50
- Negative: Industry operating cash flow per share per price (median), % of 4.53 <= 5.46
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 3.08
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term ACTG quotes
Long-term ACTG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $125.10MM | $122.31MM | $285.23MM |
| Operating Expenses | $104.17MM | $155.24MM | $278.82MM |
| Operating Income | $20.94MM | $-32.93MM | $6.41MM |
| Non-Operating Income | $46.49MM | $-5.22MM | $24.90MM |
| Interest Expense | $1.93MM | $6.44MM | $8.99MM |
| R&D Expense | $0.73MM | $0.00MM | $0.00MM |
| Income(Loss) | $67.43MM | $-38.15MM | $31.31MM |
| Taxes | $-1.50MM | $-3.45MM | $6.84MM |
| Profit(Loss)* | $67.06MM | $-36.06MM | $21.68MM |
| Stockholders Equity | $568.27MM | $514.83MM | $543.45MM |
| Inventory | $10.92MM | $27.48MM | $26.56MM |
| Assets | $633.54MM | $756.39MM | $770.96MM |
| Operating Cash Flow | $-22.51MM | $50.12MM | $75.24MM |
| Capital expenditure | $6.19MM | $148.67MM | $16.69MM |
| Investing Cash Flow | $16.18MM | $-212.96MM | $-21.01MM |
| Financing Cash Flow | $58.63MM | $97.56MM | $-22.73MM |
| Earnings Per Share** | $0.89 | $-0.36 | $0.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.